Neogenomics, Inc.
NEO
$7.88
-$0.10-1.25%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 159.62M | 164.12M | 163.69M | 358.08M | 386.84M |
| Total Receivables | 159.24M | 155.80M | 153.63M | 152.31M | 150.64M |
| Inventory | 28.57M | 28.46M | 34.17M | 29.77M | 26.75M |
| Prepaid Expenses | 21.44M | 21.99M | 22.83M | 22.98M | 20.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.42M | 12.11M | 18.24M | 10.79M | 11.62M |
| Total Current Assets | 376.29M | 382.47M | 392.55M | 573.93M | 596.02M |
|
|
|||||
| Total Current Assets | 376.29M | 382.47M | 392.55M | 573.93M | 596.02M |
| Net Property, Plant & Equipment | 163.28M | 165.62M | 168.33M | 167.41M | 173.69M |
| Long-term Investments | 524.34M | 524.34M | 524.14M | 522.77M | 522.77M |
| Goodwill | 524.34M | 524.34M | 524.14M | 522.77M | 522.77M |
| Total Other Intangibles | 286.53M | 294.16M | 301.80M | 331.32M | 339.68M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.39M | 8.19M | 7.13M | 6.01M | 5.89M |
| Total Assets | 1.36B | 1.37B | 1.39B | 1.60B | 1.64B |
|
|
|||||
| Total Accounts Payable | 23.09M | 22.61M | 27.49M | 16.21M | 21.61M |
| Total Accrued Expenses | 59.58M | 68.69M | 67.04M | 58.12M | 75.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.78M | 4.51M | 4.05M | 204.21M | 204.16M |
| Total Finance Division Other Current Liabilities | 851.00K | 2.05M | 1.54M | 1.16M | 409.00K |
| Total Other Current Liabilities | 851.00K | 2.05M | 1.54M | 1.16M | 409.00K |
| Total Current Liabilities | 88.30M | 97.87M | 100.12M | 279.70M | 301.24M |
|
|
|||||
| Total Current Liabilities | 88.30M | 97.87M | 100.12M | 279.70M | 301.24M |
| Long-Term Debt | 341.86M | 341.48M | 341.10M | 340.71M | 340.34M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 62.82M | 64.33M | 66.62M | 59.86M | 60.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 30.29M | 32.82M | 32.08M | 32.89M | 33.28M |
| Total Liabilities | 523.27M | 536.49M | 539.91M | 713.16M | 735.70M |
|
|
|||||
| Common Stock & APIC | 1.27B | 1.26B | 1.25B | 1.24B | 1.23B |
| Retained Earnings | -433.81M | -423.93M | -396.80M | -351.70M | -325.78M |
| Treasury Stock & Other | 4.00K | 71.00K | 29.00K | -56.00K | -206.00K |
| Total Common Equity | 836.56M | 838.29M | 854.04M | 888.27M | 902.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 836.56M | 838.29M | 854.04M | 888.27M | 902.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 836.56M | 838.29M | 854.04M | 888.27M | 902.34M |
|
|
|||||